(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.38%) $966.30
(-0.36%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
5 days till quarter result
(bmo 2024-05-09)
Expected move: +/- 8.21%
7.74% $ 1.010
Live Chart Being Loaded With Signals
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology...
Stats | |
---|---|
Volumen de hoy | 2.47M |
Volumen promedio | 1.33M |
Capitalización de mercado | 51.47M |
EPS | $0 ( 2024-03-18 ) |
Próxima fecha de ganancias | ( $-0.250 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.530 |
ATR14 | $0.00500 (0.50%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-28 | Grant Stuart M. | Buy | 100 000 | Common stock, par value $0.0001 |
2024-03-19 | Grant Stuart M. | Buy | 50 000 | Common stock, par value $0.0001 |
2024-03-08 | Grant Stuart M. | Buy | 10 717 | Common stock, par value $0.0001 |
2024-02-12 | Gandolfo John P | Buy | 60 000 | Stock Option (right to buy) |
2024-02-12 | Rowe Michael M | Buy | 75 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
68.92 |
Last 95 transactions |
Buy: 2 919 948 | Sell: 334 000 |
Volumen Correlación
Eyenovia Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
WINA | 0.968 |
INZY | 0.966 |
CSPI | 0.955 |
AZ | 0.948 |
HROW | 0.946 |
ESCA | 0.944 |
VMD | 0.944 |
HSKA | 0.944 |
BRLI | 0.944 |
THAC | 0.942 |
10 Correlaciones Más Negativas | |
---|---|
CYRN | -0.957 |
TLGT | -0.936 |
GNTY | -0.935 |
FVCB | -0.934 |
CDXC | -0.933 |
ONEM | -0.933 |
PEAR | -0.93 |
RPRX | -0.93 |
BWB | -0.929 |
AROW | -0.927 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Eyenovia Inc Correlación - Moneda/Commodity
Eyenovia Inc Finanzas
Annual | 2023 |
Ingresos: | $3 787.00 |
Beneficio Bruto: | $-783 208 (-20 681.49 %) |
EPS: | $-0.660 |
FY | 2023 |
Ingresos: | $3 787.00 |
Beneficio Bruto: | $-783 208 (-20 681.49 %) |
EPS: | $-0.660 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-307 430 (0.00 %) |
EPS: | $-0.820 |
FY | 2021 |
Ingresos: | $14.00M |
Beneficio Bruto: | $12.40M (88.57 %) |
EPS: | $-0.607 |
Financial Reports:
No articles found.
Eyenovia Inc
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico